These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22498682)

  • 41. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2014; (986):1-387, back cover. PubMed ID: 24964711
    [TBL] [Abstract][Full Text] [Related]  

  • 42. FDA perspective on specifications for biotechnology products--from IND to PLA.
    Murano G
    Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FDA implementation of standards developed by the International Conference on Harmonisation.
    Booth PM
    Food Drug Law J; 1997; 52(2):203-23. PubMed ID: 10557561
    [No Abstract]   [Full Text] [Related]  

  • 44. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2003; 908():i-viii, 1-136, back cover. PubMed ID: 12768889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Road rules for drugs: a survey of signals.
    Nat Med; 2010 Dec; 16(12):1362-3. PubMed ID: 21135833
    [No Abstract]   [Full Text] [Related]  

  • 46. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Fiftieth report.
    World Health Organ Tech Rep Ser; 2016; (996):1-358, back cover. PubMed ID: 27514184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multinational medicines--ensuring drug quality in an era of global manufacturing.
    Okie S
    N Engl J Med; 2009 Aug; 361(8):737-40. PubMed ID: 19692686
    [No Abstract]   [Full Text] [Related]  

  • 48. Show drugs work before selling them.
    Sipp D; McCabe C; Rasko JE
    Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530
    [No Abstract]   [Full Text] [Related]  

  • 49. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 50. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The future of pharmaceutical quality and the path to get there.
    Yu LX; Kopcha M
    Int J Pharm; 2017 Aug; 528(1-2):354-359. PubMed ID: 28619448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Post launch studies].
    Akaza H; Ohashi Y; Shimada Y; Ikeda T; Saijo N; Isonishi S; Hirao Y; Tsuruo T; Tsukagoshi S; Sone S; Nakamura S; Kato M; Mikami O; von Euler M; Blackledge G; Milsted B; Vose B
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):2037-48. PubMed ID: 12465411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Towards regulation of similar biotherapeutic products: Thailand's perspective.
    Thanaphollert P; Tungsanga K
    Biologicals; 2011 Sep; 39(5):346-7. PubMed ID: 21917474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recommendations for the registration of drugs intended for use in the treatment of male osteoporosis.
    Kaufman JM; Compston J; Audran MA; Avouac B; Devogelaer JP; Lemmel EM; Vanhaelst L; Reginster JY
    Calcif Tissue Int; 1999 Jul; 65(1):4-7. PubMed ID: 10369725
    [No Abstract]   [Full Text] [Related]  

  • 55. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
    Sahoo N; Manchikanti P
    BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmaceutical analysis: key to drug quality and control.
    Florey KG; Brewer GA
    Am Pharm; 1981 Aug; NS21(8):30-5. PubMed ID: 7270421
    [No Abstract]   [Full Text] [Related]  

  • 57. Plans look askance at me-too medications.
    Carroll J
    Manag Care; 2008 Jan; 17(1):37-8, 41-2. PubMed ID: 18274313
    [No Abstract]   [Full Text] [Related]  

  • 58. Applying Quality by Design Concepts to Pharmacy Compounding.
    Timko RJ
    Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Introduction of research on drug quality control into the pactical work of analytical control laboratories].
    Poliakova LV
    Farm Zh; 1977; 32(4):46-8. PubMed ID: 913547
    [No Abstract]   [Full Text] [Related]  

  • 60. Real world evidence for pharmaceuticals.
    Novack GD
    Ocul Surf; 2019 Jul; 17(3):584-588. PubMed ID: 31085356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.